| Line item | 2026-01-31 FY | 2025-01-31 FY | 2024-01-31 FY | 2023-01-31 FY | 2022-01-31 FY | 2021-01-31 FY |
|---|---|---|---|---|---|---|
| Revenue | – | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – |
| Operating Expenses | $4.83M | $2.58M | $1.80M | $1.56M | $1.27M | $1.01M |
| R&D | – | – | – | – | – | – |
| SG&A | – | – | – | – | – | – |
| Operating Income | – | – | – | – | – | -$1.01M |
| Interest Expense | – | – | – | – | – | – |
| Tax Expense | – | – | – | – | – | – |
| Net Income | $1.09B | $313.15M | $37.90M | $31.61M | -$16.91M | $39.33M |
| EPS (basic) | – | – | – | – | – | – |
| EPS (diluted) | – | – | – | – | – | – |
| Shares (diluted) | – | – | – | – | – | – |